Bradley Wibrow

1.7k total citations
32 papers, 430 citations indexed

About

Bradley Wibrow is a scholar working on Critical Care and Intensive Care Medicine, Pulmonary and Respiratory Medicine and Anesthesiology and Pain Medicine. According to data from OpenAlex, Bradley Wibrow has authored 32 papers receiving a total of 430 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Critical Care and Intensive Care Medicine, 11 papers in Pulmonary and Respiratory Medicine and 7 papers in Anesthesiology and Pain Medicine. Recurrent topics in Bradley Wibrow's work include Intensive Care Unit Cognitive Disorders (15 papers), Anesthesia and Neurotoxicity Research (7 papers) and Sepsis Diagnosis and Treatment (6 papers). Bradley Wibrow is often cited by papers focused on Intensive Care Unit Cognitive Disorders (15 papers), Anesthesia and Neurotoxicity Research (7 papers) and Sepsis Diagnosis and Treatment (6 papers). Bradley Wibrow collaborates with scholars based in Australia, United States and Belgium. Bradley Wibrow's co-authors include Matthew Anstey, Kwok M. Ho, Edward Litton, Andrew H. Ford, Angela Jacques, Sudhakar Rao, Alan Kop, Tomás Corcoran, F. Eduardo Martinez and Stephen Honeybul and has published in prestigious journals such as New England Journal of Medicine, PLoS ONE and Journal of the American Geriatrics Society.

In The Last Decade

Bradley Wibrow

28 papers receiving 418 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bradley Wibrow Australia 11 215 95 84 83 76 32 430
Carole Rolland France 11 343 1.6× 173 1.8× 35 0.4× 205 2.5× 52 0.7× 25 748
Jesse Hall United States 9 322 1.5× 69 0.7× 37 0.4× 27 0.3× 56 0.7× 22 528
David P. Reardon United States 10 89 0.4× 90 0.9× 55 0.7× 57 0.7× 44 0.6× 21 285
Leda Nobile Italy 14 92 0.4× 103 1.1× 79 0.9× 29 0.3× 202 2.7× 33 503
G Fontaine United States 12 87 0.4× 42 0.4× 86 1.0× 69 0.8× 42 0.6× 39 357
Stephen A. Colucciello United States 9 110 0.5× 163 1.7× 42 0.5× 102 1.2× 160 2.1× 13 436
Mark D. Sprenkle United States 9 288 1.3× 198 2.1× 99 1.2× 9 0.1× 118 1.6× 13 560
Anne Julie Frenette Canada 13 233 1.1× 84 0.9× 129 1.5× 5 0.1× 116 1.5× 36 537
A. Lechleuthner Germany 11 132 0.6× 70 0.7× 217 2.6× 75 0.9× 281 3.7× 49 600
Nathaniel H. Greene United States 13 204 0.9× 111 1.2× 100 1.2× 6 0.1× 157 2.1× 30 580

Countries citing papers authored by Bradley Wibrow

Since Specialization
Citations

This map shows the geographic impact of Bradley Wibrow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bradley Wibrow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bradley Wibrow more than expected).

Fields of papers citing papers by Bradley Wibrow

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bradley Wibrow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bradley Wibrow. The network helps show where Bradley Wibrow may publish in the future.

Co-authorship network of co-authors of Bradley Wibrow

This figure shows the co-authorship network connecting the top 25 collaborators of Bradley Wibrow. A scholar is included among the top collaborators of Bradley Wibrow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bradley Wibrow. Bradley Wibrow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Egerod, Ingrid, Mu‐Hsing Ho, Jessica A. Palakshappa, et al.. (2025). Expert consensus on research priorities for the prevention of delirium in adult ICU patients. Intensive and Critical Care Nursing. 91. 104124–104124.
3.
Layios, Nathalie, Marijke Peetermans, Mark P. Plummer, et al.. (2024). A dose‐adjusted, open‐label, pilot study of the safety, tolerability, and pharmacokinetics of STC3141 in critically ill patients with sepsis. Pharmacology Research & Perspectives. 12(5). e70015–e70015.
4.
Wood, Alexander, Rashmi Rauniyar, Angela Jacques, et al.. (2022). Oral midodrine does not expedite liberation from protracted vasopressor infusions: A case-control study. Anaesthesia and Intensive Care. 51(1). 20–28. 4 indexed citations
5.
6.
Wibrow, Bradley, et al.. (2022). A Prospective Evaluation of Grip Strength Comparing a Low-Tech Method to Dynanometry in Preoperative Surgical Patients and Weak Intensive Care Patients. Critical Care Research and Practice. 2022. 1–6. 1 indexed citations
7.
Wibrow, Bradley, F. Eduardo Martinez, Edward Litton, et al.. (2022). Prophylactic melatonin for delirium in intensive care (Pro-MEDIC): a randomized controlled trial. Intensive Care Medicine. 48(4). 414–425. 56 indexed citations
8.
Anstey, Matthew, Rashmi Rauniyar, Natalie Tran, et al.. (2022). Muscle Growth and Anabolism in Intensive Care Survivors (GAINS) trial: a pilot randomised controlled trial. Acute and Critical Care. 37(3). 295–302. 5 indexed citations
9.
Schweikert, Sacha, Matthew Anstey, Bradley Wibrow, et al.. (2022). A multicentre observational study of the use of antiseizure medication in patients with aneurysmal subarachnoid haemorrhage in the PROMOTE-SAH study. Journal of Clinical Neuroscience. 103. 20–25. 2 indexed citations
10.
Wibrow, Bradley, et al.. (2021). A prospective comparison of peripheral metaraminol versus dilute noradrenaline in the intensive care unit. Anaesthesia and Intensive Care. 49(2). 144–146. 4 indexed citations
11.
Anstey, Matthew, Imogen Mitchell, Charlie Corke, et al.. (2021). Intensive care doctors and nurses personal preferences for Intensive Care, as compared to the general population: a discrete choice experiment. Critical Care. 25(1). 287–287. 4 indexed citations
12.
Ho, Kwok M., et al.. (2021). Airway pressure release ventilation in mechanically ventilated patients with COVID-19: a multicenter observational study. Acute and Critical Care. 36(2). 143–150. 10 indexed citations
13.
Ho, Kwok M., et al.. (2021). Incidence and determinants of malpositioning tracheostomy tubes in critically ill adult patients. Anaesthesia and Intensive Care. 50(3). 243–249.
14.
Ho, Kwok M., Sudhakar Rao, Stephen Honeybul, et al.. (2019). A Multicenter Trial of Vena Cava Filters in Severely Injured Patients. New England Journal of Medicine. 381(4). 328–337. 88 indexed citations
15.
Wibrow, Bradley, et al.. (2019). The needs of patients with post–intensive care syndrome: A prospective, observational study. Australian Critical Care. 33(2). 116–122. 24 indexed citations
16.
Anstey, Matthew, et al.. (2018). Anabolic Steroid Use for Weight and Strength Gain in Critically Ill Patients: A Case Series and Review of the Literature. Case Reports in Critical Care. 2018. 1–6. 9 indexed citations
17.
18.
Martinez, F. Eduardo, Matthew Anstey, Andrew H. Ford, et al.. (2017). Prophylactic Melatonin for Delirium in Intensive Care (Pro-MEDIC): study protocol for a randomised controlled trial. Trials. 18(1). 4–4. 26 indexed citations
19.
Richards, Stephen B., et al.. (2016). Determinants of 6-month survival of critically ill patients with an active hematologic malignancy. Journal of Critical Care. 36. 252–258. 9 indexed citations
20.
Ford, Andrew H., Leon Flicker, Jürgen Passage, et al.. (2016). The Healthy Heart-Mind trial: melatonin for prevention of delirium following cardiac surgery: study protocol for a randomized controlled trial. Trials. 17(1). 55–55. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carole Rolland Breakdown of academic impact, for papers by Jesse Hall Breakdown of academic impact, for papers by David P. Reardon Breakdown of academic impact, for papers by Leda Nobile Breakdown of academic impact, for papers by G Fontaine Breakdown of academic impact, for papers by Stephen A. Colucciello Breakdown of academic impact, for papers by Mark D. Sprenkle Breakdown of academic impact, for papers by Anne Julie Frenette Breakdown of academic impact, for papers by A. Lechleuthner Breakdown of academic impact, for papers by Nathaniel H. Greene
Rankless by CCL
2026